These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38667048)

  • 1. Comparative Pharmacokinetics of Gentamicin C
    Kim EY; Kim TW; Awji EG; Lee EB; Park SC
    Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing tylosin dosage for co-infection of
    Lee EB; Abbas MA; Park J; Tassew DD; Park SC
    Front Pharmacol; 2023; 14():1258403. PubMed ID: 37808183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of gentamicin C1, C1a and C2 in horses after single intravenous dose.
    Steinman A; Isoherranen N; Ashoach O; Soback S
    Equine Vet J; 2002 Sep; 34(6):615-8. PubMed ID: 12358003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Gentamicin Components C1, C1a, and C2/C2a/C2b and Subsequent Decline in Glomerular Filtration Rate in Neonates.
    Soeorg H; Padari H; Kipper K; Ilmoja ML; Lutsar I; Metsvaht T
    AAPS J; 2022 Jun; 24(4):77. PubMed ID: 35760955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
    Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
    BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
    Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of danofloxacin in healthy and Pasteurella multocida infected ducks.
    Xiao X; Lan W; Wang Y; Jiang L; Jiang Y; Wang Z
    J Vet Pharmacol Ther; 2018 Dec; 41(6):912-918. PubMed ID: 30182430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
    Dorey L; Pelligand L; Lees P
    BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
    Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
    Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresis.
    Kaale E; Long Y; Fonge HA; Govaerts C; Desmet K; Van Schepdael A; Hoogmartens J
    Electrophoresis; 2005 Feb; 26(3):640-7. PubMed ID: 15690437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study on Pharmacokinetics of Four Long-Acting Injectable Formulations of Enrofloxacin in Pigs.
    Ahmad SU; Sun J; Cheng F; Li B; Arbab S; Zhou X; Zhang J
    Front Vet Sci; 2020; 7():604628. PubMed ID: 33575278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits.
    Elazab ST; Schrunk DE; Griffith RW; Ensley SM; Dell'Anna G; Mullin K; Elsayed MG; Amer MS; El-Nabtity SM; Hsu WH
    J Vet Pharmacol Ther; 2018 Jun; 41(3):374-377. PubMed ID: 29383736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
    Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
    N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotoxicity of the constituents of the gentamicin complex.
    Kohlhepp SJ; Loveless MO; Kohnen PW; Houghton DC; Bennett WM; Gilbert DN
    J Infect Dis; 1984 Apr; 149(4):605-14. PubMed ID: 6725992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to benzylpenicillin after different dosage regimens in growing pigs.
    Sjölund M; Ekstrand C; Wallgren P; Bondesson U; Pringle M; Bengtsson B
    Acta Vet Scand; 2020 Sep; 62(1):55. PubMed ID: 32943077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against
    Zhou Q; Zhang G; Wang Q; Liu W; Huang Y; Yu P; Li Y; Ding H; Fang B
    Front Pharmacol; 2017; 8():392. PubMed ID: 28701951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Rattanapanadda P; Kuo HC; Vickroy TW; Sung CH; Rairat T; Lin TL; Yeh SY; Chou CC
    Front Microbiol; 2019; 10():2430. PubMed ID: 31749775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.